Your browser is no longer supported. Please, upgrade your browser.
DVAX Dynavax Technologies Corporation monthly Stock Chart
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-3.75 Insider Own0.20% Shs Outstand38.40M Perf Week-4.87%
Market Cap1.09B Forward P/E- EPS next Y-3.01 Insider Trans0.00% Shs Float38.27M Perf Month2.05%
Income-101.90M PEG- EPS next Q-0.78 Inst Own69.70% Short Float9.42% Perf Quarter29.74%
Sales6.70M P/S162.25 EPS this Y9.90% Inst Trans1.46% Short Ratio5.94 Perf Half Y30.88%
Book/sh2.54 P/B11.15 EPS next Y7.70% ROA-80.40% Target Price51.00 Perf Year105.14%
Cash/sh2.43 P/C11.64 EPS next 5Y- ROE-109.70% 52W Range13.20 - 31.10 Perf YTD67.91%
Dividend- P/FCF- EPS past 5Y14.50% ROI-82.90% 52W High-8.97% Beta2.84
Dividend %- Quick Ratio4.50 Sales past 5Y-22.90% Gross Margin- 52W Low114.47% ATR1.77
Employees197 Current Ratio4.50 Sales Q/Q-46.70% Oper. Margin- RSI (14)50.83 Volatility6.23% 6.64%
OptionableYes Debt/Eq0.13 EPS Q/Q14.90% Profit Margin- Rel Volume0.32 Prev Close27.86
ShortableYes LT Debt/Eq0.11 EarningsAug 10 BMO Payout- Avg Volume607.15K Price28.31
Recom1.70 SMA20-0.20% SMA502.39% SMA20032.00% Volume196,269 Change1.62%
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Feb-22-08Upgrade Oppenheimer Perform → Outperform $8.50
Oct-03-07Initiated Credit Suisse Outperform $8
Jun-06-07Initiated Susquehanna Financial Positive
Feb-26-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-03-15 09:00AM  Dynavax to Participate in Two Upcoming Investor Conferences Marketwired
Aug-20-15 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials -6.29%
Aug-09-15 08:13PM  10-Q for Dynavax Technologies Corp. at Company Spotlight
Aug-07-15 04:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:09PM  Dynavax Technologies reports 2Q loss
04:01PM  Dynavax Reports Second Quarter 2015 Financial Results Marketwired
Jul-28-15 08:00AM  Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock Marketwired
Jul-22-15 04:08PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex +5.80%
08:15AM  Dynavax Prices Public Offering of Common Stock Marketwired
Jul-21-15 04:01PM  Dynavax Announces Proposed Public Offering of Common Stock Marketwired
Jul-09-15 04:22PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial +8.27%
02:01PM  Why Shares in Dynavax Technologies Corp Are Soaring 10% Higher Today at Motley Fool
01:40PM  Trending Now: Dynavax Technologiesn
09:00AM  Dynavax Announces Third Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) and Updates Financial Status Marketwired
Jul-07-15 09:46AM  Dynavax Technologies (DVAX) in Focus: Stock Up 8.2% - Tale of the Tape
06:00AM  4 Big-Volume Stocks to Trade for Breakouts at TheStreet
Jun-29-15 09:15AM  RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech at Insider Monkey
Jun-09-15 09:00AM  Dynavax to Present at the William Blair 35th Annual Growth Stock Health Care Conference Marketwired
Jun-02-15 10:30AM  Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog
Jun-01-15 12:01PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-28-15 04:54PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-09-15 08:09PM  10-Q for Dynavax Technologies Corp. at Company Spotlight
May-07-15 04:42PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:36PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
01:21PM  Dynavax Technologies reports 1Q loss
09:17AM  Dynavax Reports First Quarter 2015 Financial Results at noodls
09:00AM  Dynavax Reports First Quarter 2015 Financial Results Marketwired
May-06-15 08:08AM  Under $2 Stock Could Make Traders 200%-Plus Profits
Apr-17-15 12:13PM  The Shuman Law Firm Investigates Dynavax Technologies Corp. Business Wire
Mar-26-15 07:33PM  Lightning Round: This was a 'one and done' at CNBC -5.85%
07:13PM  Cramer Remix: I'm making a call on oil unrest at CNBC
Mar-25-15 06:04PM  Nasdaq stocks posting largest percentage increases AP -6.60%
Mar-23-15 12:13PM  ICYMI: Pharmaceutical Stocks Are Moving Big On Monday +10.79%
09:16AM  Stock Futures Aim Mildly Lower; Dollar Dips, Tenet Jumps On JV at Investor's Business Daily
Mar-19-15 10:46AM  Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference at noodls
10:46AM  Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference at noodls
10:46AM  Dynavax Reports Fourth Quarter and Year End 2014 Financial Results at noodls
10:46AM  Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) at noodls
Mar-16-15 07:27AM  Dynavax Technologies (DVAX) Shares March Higher, Can It Continue? - Tale of the Tape
Mar-07-15 07:08PM  10-K for Dynavax Technologies Corp. at Company Spotlight
Mar-05-15 05:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
05:11PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
06:48AM  Dynavax Technologies reports 4Q loss
06:00AM  Dynavax Reports Fourth Quarter and Year End 2014 Financial Results Marketwired
Mar-02-15 06:00AM  Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) Marketwired +6.87%
Feb-27-15 04:59PM  Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference Marketwired
Feb-19-15 04:15PM  Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Marketwired
Feb-11-15 04:39PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online
Feb-06-15 09:00AM  Dynavax Announces Laura Brege Has Joined Board of Directors and Denise Gilbert Will Retire Marketwired
Jan-12-15 04:05PM  Dynavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference Marketwired
Jan-09-15 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Dec-29-14 06:18AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ EDGAR Online
06:00AM  Dynavax Secures $40 Million Credit Facility With Hercules Technology Growth Capital Marketwired
Dec-09-14 05:20PM  Dynavax & AstraZeneca Alter Agreement for Asthma Product Zacks
06:00AM  Dynavax Announces Webcast of R&D Day Marketwired
Dec-08-14 04:14PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex EDGAR Online
12:31PM  Best biotech trades on ASH meeting: Kensho at CNBC
06:00AM  Dynavax and AstraZeneca to Advance TLR9 Agonist for Treatment of Asthma Into Phase 2a Clinical Study Marketwired
Dec-01-14 04:20PM  Dynavax Regains TLR 7/9 Inhibitor DV1179 Rights from Glaxo Zacks -5.18%
Nov-28-14 06:18AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:00AM  Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GSK Marketwired
Nov-21-14 10:07PM  Lightning Round: You're playing with fire at CNBC
Nov-11-14 04:30PM  Dynavax's Heplisav Phase III Trial Recommended to Continue Zacks
Nov-10-14 04:33PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D EDGAR Online
06:00AM  Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) Marketwired
Nov-07-14 07:08PM  10-Q for Dynavax Technologies Corp. Company Spotlight
05:05PM  Dynavax Announces One-for-Ten Reverse Stock Split Marketwired
Nov-05-14 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:07PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:18AM  Dynavax Technologies misses 3Q profit forecasts AP
06:00AM  Dynavax Reports Third Quarter 2014 Financial Results Marketwired
Oct-27-14 08:06AM  Dynavax Technologies (DVAX) Shares March Higher, Can It Continue? Zacks
Oct-14-14 04:12PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.07%
03:45PM  Dynavax Initiates Phase I/II Trial on Lymphoma Candidate Zacks
Oct-13-14 06:00AM  Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma Marketwired
Oct-07-14 04:04PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:00PM  Dynavax Announces Resignation of Dino Dina From Board of Directors Marketwired
Sep-23-14 04:00PM  Dynavax (DVAX) Completes Enrolment for Study on Heplisav Zacks
Sep-22-14 04:15PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:49AM  Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher Zacks
06:00AM  Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B(TM) Marketwired
Aug-08-14 04:10PM  Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat Zacks
Aug-07-14 04:30PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online -5.26%
04:17PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  Dynavax Reports Second Quarter 2014 Financial Results and Safety and Pharmacodynamic Results for Asthma and Lupus Drug Candidates Marketwired
Jul-30-14 08:01AM  Dynavax Technologies (DVAX) Jumps: Stock Gains 6.4% Zacks
Jul-04-14 07:52AM  Better Buy: Dynavax Technologies Corp. vs. Geron Corp. at Motley Fool
Jun-18-14 08:35AM  Will Dynavax (DVAX) Continue to Surge Higher? Zacks
Jun-09-14 04:00PM  Dynavax to Present at the William Blair 2014 Growth Stock Conference Marketwired
Jun-06-14 01:15PM  2 Small-Cap Biotechs for Your Watchlist at Motley Fool
Jun-02-14 04:00PM  Dynavax to Present at the Jefferies Global Healthcare Conference Marketwired
May-29-14 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V EDGAR Online
May-27-14 08:35AM  Dynavax (DVAX) Sees Hammer Chart Pattern: Time to Buy? Zacks
May-08-14 06:32PM  Why Dynavax Technologies Corporation Should Be on Your Watchlist at Motley Fool -12.16%
May-06-14 10:50AM  Dynavax Reports In Line Q1 Results Zacks -7.01%
May-05-14 04:46PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:31PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
09:00AM  Dynavax Reports First Quarter 2014 Financial Results Marketwired
Apr-30-14 06:00PM  Five Small Biotech Stocks Analysts Think Will Triple at Forbes
Apr-24-14 07:06AM  Ambit Biosciences Slumps: AMBI Falls 7.1% in Session Zacks
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. It development programs focus on the areas of vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company's product pipeline includes HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; SD-101, a CpG TLR9 agonist for the treatment of cancer immunotherapy that is in Phase I/II clinical trials; AZD1419, a drug candidate for the treatment of asthma, which has completed Phase I trial; DV1179, a TLR7/9 inhibitor that is in Phase I clinical trial for autoimmune or inflammatory conditions; and DV230-Nanoparticle, a second generation adjuvant that is in preclinical studies. It has a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease; and strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Plotkin Stanley ADirectorAug 26Option Exercise11.501,00011,5001,000Aug 26 04:49 PM